Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neurologix's appointments are Inspired

This article was originally published in Scrip

Executive Summary

Neurologix, a biotech developing gene therapies for disorders of the brain and central nervous system, has appointed Adrian Adams and Andrew Koven, both former employees of Inspire Pharmaceuticals. Mr Adams takes the role of chairman and CEO, and Mr Koven joins as president and chief administrative officer. Mr Adams most recently served as president and CEO of Inspire, where he led the company through a strategic acquisition by Merck & Co for $430 million. Mr Koven was most recently Inspire's executive vice-president and chief administrative and legal officer.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts